← Home
/
Zenas BioPharma, Inc. (ZBIO)
Stock Analysis
Zenas BioPharma, Inc. (ZBIO)
ZBIO
ZBIO · Market data
19.65
+5.76%
Updated: 2026-06-18 13:43 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 21.43. Holding above 19.43 keeps the current thesis intact.
✓
Fundamentals
Weak / Insufficient
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
19.43
↗
Break Above
Confirmation improves above resistance.
21.43
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 19.43
What's Driving ZBIO?
📈 Technical recovery is improving
Momentum is Neutral. Watch 21.43 for confirmation and 19.43 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 19.43 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Pattern
Triangle Compression / SYM / DOWN
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 19.43 and resistance at 21.43. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Business Lens
Long-term structure remains supportive
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
●
Profitability
Insufficient
📈 Net Income
-80.99M
≈ Insufficient
🧮 EPS (Basic)
-1.46
≈ Insufficient
Note: This is an algorithmic technical snapshot, not financial advice.